Literature DB >> 2424594

Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.

R Eeles, D M Tait, M J Peckham.   

Abstract

Lhermitte's sign is reported in 14 patients receiving chemotherapy for metastatic testicular cancer. In six patients the typical symptoms appeared during chemotherapy: in five patients within 1 month of treatment and in one patient at 2 months. The duration of symptoms ranged from 2 to approximately 8 months. No patient had received radiotherapy to the cervical or dorsal spinal cord. The complication is ascribed to cisplatin, the only drug common to all 14 patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424594

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  7 in total

Review 1.  On the significance of Lhermitte's sign in oncology.

Authors:  V Ventafridda; A Caraceni; C Martini; A Sbanotto; F De Conno
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

2.  Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement.

Authors:  W Boogerd; W W ten Bokkel Huinink; O Dalesio; W J Hoppenbrouwers; J J van der Sande
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

3.  Lhermitte's sign as a presenting symptom of primary spinal cord tumor.

Authors:  H B Newton; G L Rea
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

4.  Electric shock-like sensations in 42 cancer patients: clinical characteristics and distinct etiologies.

Authors:  A Lossos; T Siegal
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

Review 5.  A review on radiogenic Lhermitte's sign.

Authors:  Olga Esik; Tibor Csere; Klára Stefanits; Zsolt Lengyel; Géza Sáfrány; Katalin Vönöczky; Erzsébet Lengyel; Csaba Nemeskéri; Imre Repa; Lajos Trón
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

6.  Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.

Authors:  Krzysztof Brzeziński
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

7.  Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma.

Authors:  Bassem Youssef; JoAnn Shank; Jay P Reddy; Chelsea C Pinnix; George Farha; Mani Akhtari; Pamela K Allen; Michelle A Fanale; John A Garcia; Patricia H Horace; Sarah Milgrom; Grace Li Smith; Yago Nieto; Isadora Arzu; He Wang; Nathan Fowler; Maria Alma Rodriguez; Bouthaina Dabaja
Journal:  Radiat Oncol       Date:  2015-09-25       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.